BiotechTube
Hypervision Surgical

Hypervision Surgical

London, United Kingdom· Est.
hypervisionsurgical.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $1.5M

Overview

Hypervision Surgical is an early-stage MedTech company pioneering the integration of hyperspectral imaging and artificial intelligence for real-time surgical guidance. Its core platform uses safe light to non-invasively provide quantitative data on tissue physiology, enabling differentiation of structures like tumors, nerves, and blood vessels during surgery. The company, led by a seasoned team of clinicians, AI experts, and MedTech veterans, is focused on clinical development and regulatory pathways to bring its non-contact imaging system to market. With a strong academic foundation and strategic advisors, it is positioned to address a significant unmet need in precision surgery.

NeurosurgeryOncology

Technology Platform

AI-powered hyperspectral imaging system for real-time, non-contact, wide-field intraoperative tissue characterization and differentiation without exogenous contrast agents.

Funding History

1
Total raised:$1.5M
Seed$1.5M

Opportunities

The technology addresses a critical unmet need for objective, real-time tissue guidance in high-stakes surgeries like brain tumor resection, where outcomes are directly tied to surgical precision.
The platform's agent-free, wide-field capability is highly differentiated from existing tools and could be expanded into other surgical specialties such as oncology, reconstructive, and vascular surgery.
The experienced leadership team, including veterans from CMR Surgical and NOVADAQ, provides a strong foundation for clinical translation and commercial strategy.

Risk Factors

Key risks include the technical challenge of validating the AI algorithms and hyperspectral imaging in large-scale clinical trials to meet regulatory standards.
The company must also navigate complex reimbursement pathways and overcome commercialization barriers in a surgical market dominated by large, established players.
Competition from evolving existing technologies (e.g., advanced fluorescence imaging) and other novel guidance startups presents an ongoing market risk.

Competitive Landscape

Hypervision competes in the surgical imaging market against large incumbents like Stryker (with its SPY/PINPOINT fluorescence systems), Karl Storz, and Medtronic, as well as standard techniques like MRI neuronavigation and intraoperative ultrasound. Its primary differentiation is the combination of non-contact, wide-field, contrast-agent-free imaging with AI-driven quantitative tissue analysis. It may also face future competition from other startups exploring hyperspectral or other advanced optical imaging techniques for surgery.

More companies in United Kingdom →